查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1753933

2025-2033年獸用疫苗市場報告（依疫苗類型、技術、給藥途徑、配銷通路及地區）

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球獸用疫苗市場規模達147億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到296億美元，2025-2033年期間的複合年成長率（CAGR）為7.71%。市場成長主要源自於人們對獸醫保健日益成長的關注、牲畜保險需求以及新型獸醫疫苗的推出。目前，北美佔據市場主導地位，因為該地區寵物主人數量不斷增加、獸醫保健基礎設施先進，畜牧業規模龐大。

獸用疫苗是指經由腸外或口服途徑給予家畜或野生動物的生物製劑免疫，以刺激保護性免疫反應，而不會引發疾病本身。獸用疫苗包括去活化疫苗、減毒活疫苗和重組疫苗等常見疫苗。這些疫苗有助於減輕動物痛苦，增強免疫力，並預防各種傳染性人畜共通傳染病的發生和傳播風險。

獸用疫苗市場趨勢：

獸醫保健日益受到關注

根據IMARC Group的報告，全球獸醫保健市場規模在2023年達到433億美元。隨著越來越多的人成為寵物主人，他們也更加重視寵物的健康，增加了獸醫預約和預防性治療的次數。疫苗接種是保持寵物健康的重要方面，這推動了對獸醫疫苗的需求。大眾越來越意識到預防動物疾病而非僅僅治療疾病的必要性，這為獸醫疫苗市場提供了良好的前景。疫苗接種是一種非常有效的預防措施，使其成為伴侶動物和牛隻獸醫保健方案的重要組成部分。寵物主人和牲畜生產者願意在醫療保健方面（包括疫苗）支付更多費用，以預防可能損害動物健康和生產力的疾病。這種趨勢正在催化對各種免疫接種的需求，尤其是在獸醫服務變得越來越容易獲得的情況下。

牲畜保險需求不斷成長

IMARC Group的報告顯示，2023年全球牲畜保險市場規模達36億美元。許多牲畜保險單要求接種常見疾病疫苗作為承保條件。投保的農民和牲畜所有者有動力為他們的牲畜接種疫苗以履行保單義務，這對獸用疫苗市場佔有率產生了積極影響。牲畜保險通常用於降低因疾病、意外或自然災害造成的牲畜損失相關的財務風險。為牲畜接種疫苗的農民降低了疾病爆發的風險，使他們的牲畜更容易投保，並降低了索賠的可能性。這鼓勵了定期接種疫苗，從而增加了疫苗需求。

新品發布

新型獸用疫苗正在研發中，用於對抗正在發展中的疾病以及新發現的動物病原體。隨著先前未知或正在發展的疾病的爆發，對新型疫苗的需求不斷成長，從而推動了獸用疫苗市場的成長。重組疫苗、DNA疫苗和基於載體的疫苗等新一代疫苗，提高了動物疾病預防的有效性和安全性。這些新型疫苗通常更有效、副作用更少、保護期更長，因此對醫生和寵物主人更具吸引力。新推出的疫苗通常一次注射即可覆蓋多種疾病或病毒株，讓獸醫和寵物主人的工作更加輕鬆。

本報告回答的關鍵問題：

  • 全球獸用疫苗市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球獸用疫苗市場有何影響？
  • 主要的區域市場有哪些？
  • 根據疫苗類型，市場如何分佈？
  • 基於技術的市場區隔是怎樣的？
  • 根據行政路徑，市場如何分類？
  • 根據配銷通路，市場如何分類？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球獸用疫苗市場的結構是怎麼樣的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球獸用疫苗市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依疫苗類型

  • 牲畜疫苗
    • 關鍵部分
      • 牛疫苗
      • 家禽疫苗
      • 豬疫苗
      • 其他
  • 伴侶動物疫苗
    • 關鍵部分
      • 犬類疫苗
      • 貓疫苗
      • 馬疫苗

第7章：市場區隔：依技術

  • 減毒活疫苗
  • 去活化疫苗
  • 類毒素疫苗
  • 重組疫苗
  • 其他

第8章：市場區隔：依行政途徑

  • 皮下
  • 肌肉注射
  • 鼻內

第9章：市場區隔：按配銷通路

  • 獸醫院
  • 獸醫診所
  • 藥局和藥局
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco Animal Health Incorporated
    • Hester Biosciences Limited
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Virbac SA
    • Zoetis Inc.
Product Code: SR112025A6493

The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033. The market is driven primarily because of the growing focus on veterinary healthcare, need for livestock insurance and the launch of new veterinary vaccinations. At present, North America dominates the market because of the rising number of pet parents, advanced veterinary healthcare infrastructure, and significant livestock industry.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases.

Veterinary Vaccines Market Trends:

Growing focus on veterinary healthcare

According to the IMARC Group's report, the global veterinary healthcare market reached USD 43.3 Billion in 2023. As more individuals are becoming pet parents, there is a greater emphasis on their well-being, resulting in increased veterinary appointments and preventive treatment. Vaccinations are an important aspect of keeping pets healthy, which is driving the demand for veterinary vaccinations. The growing awareness among the masses about the necessity of preventing animal diseases rather than simply treating them is offering a favorable veterinary vaccines market outlook. Vaccination is a very efficient preventive measure, making it an essential component of veterinary healthcare regimens for both companion animals and cattle. Pet parents and livestock producers are willing to pay more on healthcare, including vaccines, to prevent diseases that could harm animal health and productivity. This tendency is catalyzing the demand for a wide variety of immunizations, particularly as veterinary services become more accessible.

Increasing demand for livestock insurance

The IMARC Group's report shows that the global livestock insurance market reached USD 3.6 Billion in 2023. Many livestock insurance policies demand vaccinations against common diseases as a condition of coverage. Insured farmers and livestock owners are incentivized to vaccinate their animals to meet policy obligations, which is positively influencing the veterinary vaccines market share. Livestock insurance is generally used to reduce the financial risks connected with livestock loss caused by disease, accidents, or natural catastrophes. Farmers who vaccinate their animals lessen the chance of disease outbreaks, making their livestock more insurable and lowering the possibility of claims. This encourages regular vaccinations, which increases vaccine demand.

New launches

New veterinary vaccinations are being produced to combat developing diseases and newly discovered pathogens impacting animals. As outbreaks of previously unknown or developing illnesses are arising, the demand for novel vaccines is rising, thereby propelling veterinary vaccines market growth. Next-generation vaccines, such as recombinant, DNA, and vector-based vaccinations, improve the efficacy and safety of disease prevention in animals. These new vaccines are frequently more effective, have fewer side effects, and give longer-lasting protection, making them more appealing to physicians and pet owners. New releases frequently feature vaccines that cover many diseases or strains in a single shot, making life easier for vets and owners.

Key Market Segmentation:

Breakup by Vaccine Type:

  • Livestock Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Porcine Vaccines
    • Others
  • Companion Animal Vaccines
    • Canine Vaccines
    • Feline Vaccines
    • Equine Vaccines

Breakup by Technology:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

Breakup by Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Virbac SA
  • Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Livestock Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bovine Vaccines
      • 6.1.2.2 Poultry Vaccines
      • 6.1.2.3 Porcine Vaccines
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Companion Animal Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Canine Vaccines
      • 6.2.2.2 Feline Vaccines
      • 6.2.2.3 Equine Vaccines
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Attenuated Live Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Inactivated Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxoid Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Recombinant Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Subcutaneous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Veterinary Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmacies and Drug Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Sante Animale
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Hester Biosciences Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 HIPRA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indian Immunologicals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Neogen Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phibro Animal Health Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Virbac SA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Zoetis Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2024
  • Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
  • Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
  • Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
  • Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Veterinary Vaccines Market: Competitive Structure
  • Table 8: Global: Veterinary Vaccines Market: Key Players